ammonium hydroxide has been researched along with Acute Hepatic Failure in 181 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
Excerpt | Relevance | Reference |
---|---|---|
"Acute liver failure (ALF) is characterized neuropathologically by cytotoxic brain edema and biochemically by increased brain ammonia and its detoxification product, glutamine." | 8.88 | Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. ( Butterworth, RF; Desjardins, P; Du, T; Jiang, W; Peng, L, 2012) |
" The current investigation was designed to evaluate the role of taurine treatment on the brain and liver mitochondrial function in a rat model of hepatic encephalopathy and hyperammonemia." | 7.85 | Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. ( Abasvali, M; Abdoli, N; Asadi, B; Azarpira, N; Heidari, R; Jafari, F; Jamshidzadeh, A; Khodaei, F; Latifpour, Z; Mardani, E; Najibi, A; Ommati, MM; Yeganeh, Y; Zarei, A; Zarei, M, 2017) |
"Citrullinemia type I (CTLN1) is a urea cycle disorder which typically presents in the neonatal period or infancy with hyperammonemia and concurrent neurologic deterioration." | 7.77 | Transient fulminant liver failure as an initial presentation in citrullinemia type I. ( Baruteau, J; de Baulny, HO; Faghfoury, H; Häberle, J; Schulze, A, 2011) |
"L-Ornithine and phenylacetate act synergistically to successfully attenuate increases in arterial ammonia, which is accompanied by a significant decrease in extracellular brain ammonia and prevention of intracranial hypertension in pigs with ALF." | 7.75 | L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. ( Cobos, MJ; Fuskevåg, OM; Jalan, R; Kalstad, T; Kristiansen, RG; Maehre, H; Revhaug, A; Rose, CF; Ytrebø, LM, 2009) |
" Of the reported serious adverse events (AEs), which included 11 deaths, none was attributable to study medication." | 5.48 | Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. ( Bukofzer, S; Clasen, K; Durkalski, V; Fontana, RJ; Ganger, D; Gottfried, M; Hameed, B; Hanje, AJ; Koch, D; Lee, WM; Little, L; Ravis, WR; Sherker, A; Stravitz, RT; Subramanian, RM, 2018) |
"Hepatic encephalopathy is a neuropsychiatric disorder of complex pathogenesis caused by acute or chronic liver failure." | 5.37 | Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. ( Avraham, Y; Berry, E; Grigoriadis, N; Ilan, Y; Magen, I; Mechoulam, R; Poutahidis, T; Vorobiev, L, 2011) |
"The treatment with flumazenil completely abolished the decrease in the metabolite (P < 0." | 5.33 | Flumazenil-induced improvement of the central dopaminergic system in rats with acute hepatic failure. ( Adachi, N; Arai, T; Liu, K; Yano, M, 2005) |
"Its role in acute hepatic failure (AHF) is controversial." | 5.32 | The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat. ( Hodgson, HJ; Rahman, TM, 2003) |
"Acute liver failure (ALF) is characterized neuropathologically by cytotoxic brain edema and biochemically by increased brain ammonia and its detoxification product, glutamine." | 4.88 | Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. ( Butterworth, RF; Desjardins, P; Du, T; Jiang, W; Peng, L, 2012) |
" The current investigation was designed to evaluate the role of taurine treatment on the brain and liver mitochondrial function in a rat model of hepatic encephalopathy and hyperammonemia." | 3.85 | Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. ( Abasvali, M; Abdoli, N; Asadi, B; Azarpira, N; Heidari, R; Jafari, F; Jamshidzadeh, A; Khodaei, F; Latifpour, Z; Mardani, E; Najibi, A; Ommati, MM; Yeganeh, Y; Zarei, A; Zarei, M, 2017) |
"Citrullinemia type I (CTLN1) is a urea cycle disorder which typically presents in the neonatal period or infancy with hyperammonemia and concurrent neurologic deterioration." | 3.77 | Transient fulminant liver failure as an initial presentation in citrullinemia type I. ( Baruteau, J; de Baulny, HO; Faghfoury, H; Häberle, J; Schulze, A, 2011) |
"The pathogenesis of brain edema in an experimental model of ALF involves a cytotoxic mechanism: the metabolism of ammonia in astrocytes induces an increase of glutamine and lactate that appears to mediate cellular swelling." | 3.76 | Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. ( Alonso, J; Chavarria, L; Cordoba, J; Lope-Piedrafita, S; Oria, M; Romero-Gimenez, J, 2010) |
"L-Ornithine and phenylacetate act synergistically to successfully attenuate increases in arterial ammonia, which is accompanied by a significant decrease in extracellular brain ammonia and prevention of intracranial hypertension in pigs with ALF." | 3.75 | L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. ( Cobos, MJ; Fuskevåg, OM; Jalan, R; Kalstad, T; Kristiansen, RG; Maehre, H; Revhaug, A; Rose, CF; Ytrebø, LM, 2009) |
" The aim of this study was to assess the effects of simvastatin on rats with TAA-induced acute liver damage and hepatic encephalopathy." | 3.74 | Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy. ( Chan, CY; Chang, FY; Chen, YC; Chu, CJ; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS, 2008) |
" ALF pigs developed hyperammonemia and increased glutamine levels, whereas glutamate levels were decreased." | 3.73 | Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure. ( Davies, NA; Deutz, NE; Hodges, S; Jalan, R; Nedredal, GI; Revhaug, A; Romero-Gomez, M; Rose, C; Sen, S; Ten Have, GA; Williams, R; Ytrebø, LM, 2006) |
"We investigated the role of brain peripheral-type benzodiazepine receptors (PBRs) and pregnenolone (a product of PBRs activation) in hepatic encephalopathy (HE)/hyperammonemia." | 3.69 | Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. ( Dombro, RS; Itzhak, Y; Norenberg, MD; Roig-Cantisano, A, 1995) |
"About 20% of patients with acute liver failure (ALF) die from increased intracranial pressure (ICP) while awaiting transplantation." | 2.71 | Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. ( Deutz, NE; Hayes, PC; Jalan, R; Lee, A; Olde Damink, SW, 2004) |
"Patients with acute liver failure were treated with an ECHS device utilizing continuous hemodiafiltration with continuous albumin dialysis." | 2.70 | Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. ( Awad, SS; Bartlett, RH; Magee, J; Punch, J; Swaniker, F, 2001) |
"In patients with acute liver failure cerebral microdialysis studies show a linear correlation between the lactate to pyruvate ratio and the glutamine concentration, as well as to some of the adenosine triphosphate degradation products." | 2.49 | Changes in cerebral oxidative metabolism in patients with acute liver failure. ( Bjerring, PN; Larsen, FS, 2013) |
"Hyperammonemia in end-stage acute liver failure (ALF) is often associated with cerebral edema and astrocyte pathology/swelling." | 2.49 | Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. ( Cooper, AJ, 2013) |
"Hepatic encephalopathy is a medical phenomenon that is described as a neuropsychiatric manifestation of chronic or acute liver disease that is characterized by psychomotor, intellectual and cognitive abnormalities with emotional/affective and behavioral disturbances." | 2.49 | Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. ( Cichoż-Lach, H; Michalak, A, 2013) |
"The mechanisms responsible for cerebral edema in ALF suggest both cytotoxic and vasogenic injury." | 2.48 | Neuropathology of acute liver failure. ( Dhiman, RK; Taneja, S; Thumburu, KK; Vasishta, RK, 2012) |
"Patients with hepatic encephalopathy exhibit sings of energy impairment that may participate in the development of disturbances in neurotransmission." | 2.47 | Acute-on-chronic liver failure: the brain. ( Córdoba, J; García-Martínez, R, 2011) |
"Acute liver failure is a severe condition with a very unfavourable prognosis." | 2.46 | [Intracranial hypertension in acute liver failure and microdialysis]. ( Lásziková, E; Prazák, J; Ryska, M; Ryska, O, 2010) |
"Hepatic encephalopathy is a syndrome whose pathophysiology is poorly understood, for which we lack high-quality diagnostic tests and markers, and whose treatment has improved only slightly over the last several decades." | 2.46 | Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure. ( O'connor, M; Zafirova, Z, 2010) |
"Acute liver failure is a rare disorder with high mortality and resource cost." | 2.46 | Acute liver failure. ( Auzinger, G; Bernal, W; Dhawan, A; Wendon, J, 2010) |
"Systemic hyperammonemia has been largely found in patients with cirrhosis and hepatic encephalopathy, and ammonia plays a major role in the pathogenesis of hepatic encephalopathy." | 2.45 | Gut ammonia production and its modulation. ( Galán, JJ; Jover, M; Romero-Gómez, M; Ruiz, A, 2009) |
"When hyperammonemia is not thought to be the result of liver failure, treatment for an occult disorder of metabolism must begin prior to the confirmation of an etiology." | 2.44 | Hyperammonemia in the ICU. ( Clay, AS; Hainline, BE, 2007) |
"Mechanical hyperventilation has a prompt effect on intracranial pressure." | 2.44 | The effect of hyperventilation upon cerebral blood flow and metabolism in patients with fulminant hepatic failure. ( Strauss, GI, 2007) |
"Brain edema with intracranial hypertension is a major complication in patients with acute liver failure." | 2.43 | Mild hypothermia for acute liver failure: a review of mechanisms of action. ( Blei, AT; Vaquero, J, 2005) |
"Hyperammonemic disorders such as acute liver failure (ALF) or urea cycle enzymopathies are associated with hyperexcitability, seizures, brain edema and increased extracellular brain glutamate." | 2.43 | Effect of ammonia on astrocytic glutamate uptake/release mechanisms. ( Rose, C, 2006) |
"Increased brain ammonia may cause brain swelling via the osmotic effects of an increase in astrocytic glutamine concentration or by inhibition of glutamate removal from brain extracellular space." | 2.42 | Brain edema in acute liver failure. ( Butterworth, RF, 2003) |
"Distinct syndromes are identified in acute liver failure and cirrhosis." | 2.42 | The molecular pathogenesis of hepatic encephalopathy. ( Davies, N; Jalan, R; Shawcross, D, 2003) |
"Comparison of HE in acute liver failure (ALF) with that of cirrhosis allows recognition of important differences and similarities." | 2.42 | Pathogenesis of hepatic encephalopathy in acute liver failure. ( Blei, AT; Cahill, ME; Chung, C; Vaquero, J, 2003) |
"In 20 patients with acute liver failure, mean hepatic blood flow was increased." | 2.41 | Splanchnic circulation and metabolism in patients with acute liver failure. ( Clemmesen, O, 2002) |
"Experimental acute liver failure also results in post-translational modifications of the serotonin and noradrenaline transporters resulting in increased extracellular concentrations of these monoamines." | 2.41 | Alterations in expression of genes coding for key astrocytic proteins in acute liver failure. ( Bélanger, M; Butterworth, RF; Desjardins, P, 2001) |
"We successfully established a reproducible Tibetan miniature pig model of d-galactosamine-induced ALF, and we believe that a dosage of 0." | 1.91 | Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system. ( Cai, L; Feng, L; Fu, Y; Gao, Y; Jiang, Z; Liu, S; Wang, Y; Xu, X; Zhang, L; Zhou, C, 2023) |
"Outcome of pediatric acute liver failure (PALF) in countries with limited availability of LT is not well described." | 1.72 | Etiology, outcome and prognostic indicators of acute liver failure in Asian children. ( Chew, KS; Choong, CL; Kam, CC; Koay, ZL; Lee, WS; Ng, RT; Ranai, NBM; Song, ZL; Teh, JKL; Wong, SY, 2022) |
"BBD can prevent and cure hepatic encephalopathy (HE) derived from both chronic and acute liver diseases." | 1.56 | BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. ( An, YT; Bahaji Azami, NL; Lu, BJ; Lu, L; Sun, MY; Wang, HJ; Wang, Z; Wu, C; Xie, D; Ye, G, 2020) |
"C3A cells cultured with acute liver failure plasma showed mild inhibition of cell viabilities, reduction of albumin secretion, and increase of ammonia accumulation." | 1.56 | Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma. ( Huang, KZ; Li, LJ; Li, ZH; Ouyang, XX; Xie, ZY; Yu, J; Yu, XP; Zhang, YH; Zhao, YL; Zhu, DH, 2020) |
"Hyperammonemia is a key contributing factor for cerebral edema in acute liver failure." | 1.56 | Correction and Control of Hyperammonemia in Acute Liver Failure: The Impact of Continuous Renal Replacement Timing, Intensity, and Duration. ( Bellomo, R; Fisher, C; Warrillow, S, 2020) |
"Its efficacy in acute liver failure has been suggested but further investigation is required to prove this." | 1.56 | Continuous renal replacement therapy and transplant-free survival in acute liver failure: protocol for a systematic review and meta-analysis. ( Dionne, JC; Featherstone, R; Karvellas, CJ; Rewa, OG; Robinson, AM; Sebastianski, M; Vandermeer, B, 2020) |
"Neurological symptoms of acute liver failure (ALF) reflect decreased excitatory transmission, but the status of ALF-affected excitatory synapse has not been characterized in detail." | 1.48 | Cortical Synaptic Transmission and Plasticity in Acute Liver Failure Are Decreased by Presynaptic Events. ( Albrecht, J; Bobula, B; Filipkowski, RK; Frontczak-Baniewicz, M; Hess, G; Polowy, R; Popek, M; Sowa, J; Zabłocka, B; Zielińska, M, 2018) |
" Of the reported serious adverse events (AEs), which included 11 deaths, none was attributable to study medication." | 1.48 | Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. ( Bukofzer, S; Clasen, K; Durkalski, V; Fontana, RJ; Ganger, D; Gottfried, M; Hameed, B; Hanje, AJ; Koch, D; Lee, WM; Little, L; Ravis, WR; Sherker, A; Stravitz, RT; Subramanian, RM, 2018) |
"On multivariate analysis, presence of cerebral edema(HR 2." | 1.46 | Predictors of infection in viral-hepatitis related acute liver failure. ( Acharya, SK; Kedia, S; Sharma, H; Sonika, U; Upadhyaya, AD; Vasudevan, S, 2017) |
"We successfully established a simplified, reproducible D-galactosamine-induced cynomolgus monkey model of acute liver failure, and the single or divided dosage of 0." | 1.46 | Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure. ( Cai, L; Feng, L; Gao, Y; He, GL; Jiang, ZS; Li, Y; Pan, MX; Peng, Q; Weng, J, 2017) |
"Of 165 children admitted with pediatric acute liver failure, 136 met the inclusion criteria and 45 of these received continuous renal replacement therapy prior to transplantation or recovery." | 1.43 | Effect of Continuous Renal Replacement Therapy on Outcome in Pediatric Acute Liver Failure. ( Deep, A; Dhawan, A; Douiri, A; Stewart, CE, 2016) |
"BACKGROUND Acute liver failure (ALF) is an emergent condition that requires intensive care and manifests in particular by significant elevation in serum ammonia level." | 1.43 | Ammonia Level and Mortality in Acute Liver Failure: A Single-Center Experience. ( Alachkar, N; Alqahtani, S; Araz, F; Cameron, AM; Gurakar, A; Niranjan-Azadi, AM; Patel, YA; Stevens, RD, 2016) |
"Glycine is an important ammoniagenic amino acid, which is increased in acute liver failure (ALF)." | 1.40 | L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway. ( Fuskevåg, OM; Jalan, R; Kristiansen, RG; Mæhre, H; Revhaug, A; Rose, CF; Ytrebø, LM, 2014) |
"Because fulminant Wilson disease (WD) has an extremely poor prognosis, the use of liver support that can bridge patients to liver transplantation is lifesaving." | 1.40 | Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease. ( Boillot, O; Bordet, F; Bost, M; Brunet, AS; Cour-Andlauer, F; Javouhey, E; Lachaux, A; Richard, N; Rustom, N; Valla, F, 2014) |
"Astrocyte swelling (cytotoxic brain edema) is the major neurological complication of acute liver failure (ALF), a condition in which ammonia has been strongly implicated in its etiology." | 1.40 | Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure. ( Gonzalez, W; Jayakumar, AR; Norenberg, MD; Shamaladevi, N; Tong, XY; Valdes, V, 2014) |
"Mortality of patients with acute liver failure (ALF) is still unacceptably high." | 1.39 | Evaluation of the Hepa Wash® treatment in pigs with acute liver failure. ( Al-Chalabi, A; Huber, W; Kreymann, B; Luppa, P; Matevossian, E; Nairz, E; Neiss, A; Perren, A; Radermacher, P; Schimmel, P; Schmid, RM; Schreiber, C; Schuster, T; V Thaden, AK; Yang, Z, 2013) |
"Cerebral edema is a well-recognized and potentially fatal complication of acute liver failure (ALF)." | 1.39 | Cerebral microdialysis reflects the neuroprotective effect of fractionated plasma separation and adsorption in acute liver failure better and earlier than intracranial pressure: a controlled study in pigs. ( Koblihova, E; Laszikova, E; Pantoflicek, T; Prazak, J; Ryska, M; Ryska, O, 2013) |
"Brain edema is a major neurological complication of acute liver failure (ALF) and swelling of astrocytes (cytotoxic brain edema) is the most prominent neuropathological abnormality in this condition." | 1.39 | Brain edema in acute liver failure: role of neurosteroids. ( Jayakumar, AR; Norenberg, MD; Ruiz-Cordero, R; Tong, XY, 2013) |
"Specific treatments of hyperammonemia are rarely used in liver failure when compared with urea cycle defect even though use of ammonia scavengers may help to decrease ammonemia." | 1.38 | Threshold for toxicity from hyperammonemia in critically ill children. ( Alvarez, F; Cousineau, J; Ducruet, T; Jouvet, P; Lambert, M; Mitchell, G; Nelson, J; Ozanne, B; Phan, V, 2012) |
"Patients admitted to the hospital with acute liver failure (ALF) and high arterial levels of ammonia are more likely to have complications and poor outcomes than patients with lower levels of ammonia." | 1.38 | Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. ( Acharya, SK; Khanal, S; Kumar, R; Panda, SK; Prakash, S; Sharma, H, 2012) |
"Patients with acute liver failure (ALF) often die of intracranial pressure (IP) and cerebral herniation." | 1.37 | Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. ( Agusti, A; Boix, J; Cauli, O; Cerdán, S; Felipo, V; López-Larrubia, P; Nieto-Charques, L; Rodrigo, R, 2011) |
"Fulminant hepatic failure is associated with transcerebral ammonia uptake, which is fully and rapidly corrected by liver transplantation." | 1.37 | Liver transplantation rapidly stops cerebral ammonia uptake in fulminant hepatic failure. ( Bellomo, R; Farley, KJ; Glassford, NJ; Warrillow, S, 2011) |
"Hepatic encephalopathy is a neuropsychiatric disorder of complex pathogenesis caused by acute or chronic liver failure." | 1.37 | Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. ( Avraham, Y; Berry, E; Grigoriadis, N; Ilan, Y; Magen, I; Mechoulam, R; Poutahidis, T; Vorobiev, L, 2011) |
"Acute liver failure was surgically induced in swine by complete hepatectomy (n = 8)." | 1.37 | Neuromonitoring in a porcine model of acute hepatic failure. ( Frühauf, NR; Grabellus, F; Kaiser, GM; Laube, T; Radunz, S; Uerschels, AK, 2011) |
"Besides, SC-560 treatment improved hepatic encephalopathy and decrease plasma levels of PGF(1α), but did not change TNF-α levels." | 1.37 | Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat. ( Chan, CY; Chang, CC; Chuang, CL; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Nong, JY; Wang, SS, 2011) |
"To develop a reliable surgical model of acute hepatic failure and hyperammonemia in rats that avoids porto-systemic shunt and bile duct ligation, applicable to hepatic encephalopathy research." | 1.36 | A new experimental model for acute hepatic failure in rats. ( Bellodi-Privato, M; D'Albuquerque, LA; Kubrusly, MS; Leite, KR; Machado, MC; Molan, NT; Teixeira, AR, 2010) |
"There is evidence to suggest that, in acute liver failure (ALF), brain ammonia and proinflammatory cytokines may act synergistically to cause brain edema and its complications (intracranial hypertension, brain herniation)." | 1.36 | Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure. ( Butterworth, RF; Chastre, A; Desjardins, P; Jiang, W, 2010) |
"In 87 patients with acute liver failure admitted to the intensive care unit, we simultaneously evaluated arterial ammonia, pNH(3), clinical grade of hepatic encephalopathy, the sequential organ failure assessment score (SOFA score), and evidence of intracranial hypertension." | 1.35 | Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. ( Ferenci, P; Funk, GC; Holzinger, U; Kaider, A; Kitzberger, R; Kramer, L; Madl, C; Miehsler, W, 2009) |
"Pediatric acute liver failure (PALF) results in death or need for liver transplantation (LT) in up to 50% of patients." | 1.35 | Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. ( Dobyns, EL; Gralla, J; Liu, E; Lu, BR; Narkewicz, MR; Sokol, RJ, 2008) |
"After transplantation into mice with acute liver failure, ASC-derived hepatocytes can restore such liver functions as ammonia and purine metabolism." | 1.35 | Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. ( Banas, A; Kato, T; Ochiya, T; Okochi, H; Osaki, M; Takeshita, F; Teratani, T; Tokuhara, M; Yamamoto, Y, 2009) |
"Hyperammonemia is a main contributor to brain herniation and mortality in acute liver failure (ALF)." | 1.35 | Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain. ( Agusti, A; Boix, J; Cauli, O; Felipo, V; Piedrafita, B; Rodrigo, R, 2008) |
"Patients with acute liver failure (ALF) display impairment of cerebral blood flow (CBF) autoregulation, which may contribute to the development of fatal intracranial hypertension, but the pathophysiological mechanism remains unclear." | 1.35 | Cerebral blood flow autoregulation in experimental liver failure. ( Dethloff, TJ; Knudsen, GM; Larsen, FS, 2008) |
"We previously demonstrated in pigs with acute liver failure (ALF) that albumin dialysis using the molecular adsorbents recirculating system (MARS) attenuated a rise in intracranial pressure (ICP)." | 1.34 | Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. ( Belanger, M; Davies, NA; Jalan, R; Nedredal, GI; Revhaug, A; Rose, C; Sen, S; Ytrebø, LM, 2007) |
"The cause of liver failure included acute liver failure (n = 2), acute on chronic liver failure (n = 12), posthepatectomy liver failure (n = 4), and posttransplantation allograft failure (n = 4)." | 1.33 | Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. ( Chan, LM; Chiu, A; Fan, ST, 2006) |
"In the experiments of BAL in vitro, acute liver failure (ALF) model in canine was induced by an end-side portocaval shunt combined with common bile duct ligation and transaction." | 1.33 | Functional evaluation of a new bioartificial liver system in vitro and in vitro. ( Chen, Z; Ding, YT, 2006) |
"The initial development of cerebral edema and increased ICP occurs independently of CBF changes in this noninflammatory model of ALF." | 1.33 | Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. ( Butterworth, RF; Davies, NA; Deutz, NE; Drevland, SS; Hodges, SJ; Jalan, R; Kjønnø, M; Nedredal, GI; Prinzen, FW; Revhaug, A; Rose, C; Sen, S; Williams, R; Ytrebø, LM, 2006) |
"The treatment with flumazenil completely abolished the decrease in the metabolite (P < 0." | 1.33 | Flumazenil-induced improvement of the central dopaminergic system in rats with acute hepatic failure. ( Adachi, N; Arai, T; Liu, K; Yano, M, 2005) |
"It has been proposed that, in acute liver failure, skeletal muscle adapts to become the principle organ responsible for removal of blood-borne ammonia by increasing glutamine synthesis, a reaction that is catalyzed by the cytosolic ATP-dependent enzyme glutamine synthetase." | 1.33 | Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure. ( Butterworth, RF; Chatauret, N; Desjardins, P; Rao, KV; Rose, C; Zwingmann, C, 2006) |
"Its role in acute hepatic failure (AHF) is controversial." | 1.32 | The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat. ( Hodgson, HJ; Rahman, TM, 2003) |
"In patients with acute liver failure, hyperammonemia is associated with cerebral herniation." | 1.31 | Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. ( Clemmesen, JO; Kondrup, J; Ott, P, 2000) |
"Patients with fulminant hepatic failure (FHF) often die awaiting liver transplantation." | 1.31 | Extracorporeal liver perfusion using human and pig livers for acute liver failure. ( Collier, DS; Dixon, RS; Fox, IJ; Fristoe, LW; Hammel, JM; Horslen, SP; Kangas, JA; Langnas, AN; Prentice, ED; Shaw, BW; Sudan, DL, 2000) |
"We conclude that during acute liver failure and acute hyperammonemia in the rabbit there is no decreased glutamate availability in the extracellular space of the cortical brain; on the contrary, we found evidence for increased extracellular glutamate concentrations in the cortical brain, which were more pronounced in acute liver failure." | 1.29 | Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. ( Dalm, E; de Knegt, RJ; Fekkes, D; Hekking-Weyma, I; Schalm, SW; van der Rijt, CC, 1994) |
"Acute hepatic failure is associated with many biochemical abnormalities in plasma and brain." | 1.29 | Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. ( DeJoseph, MR; Hawkins, RA; Mans, AM, 1994) |
"All rabbits with acute liver failure or acute hyperammonemia developed severe encephalopathy, after 13." | 1.29 | 45CaCl2 autoradiography in brain from rabbits with encephalopathy from acute liver failure or acute hyperammonemia. ( de Knegt, RJ; Gramsbergen, JB; Schalm, SW, 1994) |
"Other abnormalities found were cerebral edema and lactic acidosis." | 1.29 | Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study. ( de Knegt, RJ; Groeneweg, M; Hekking-Weijma, I; Schalm, SW, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (6.63) | 18.2507 |
2000's | 78 (43.09) | 29.6817 |
2010's | 80 (44.20) | 24.3611 |
2020's | 11 (6.08) | 2.80 |
Authors | Studies |
---|---|
Hui, WF | 1 |
Cheung, WL | 1 |
Chung, FS | 1 |
Leung, KKY | 1 |
Ku, SW | 1 |
Ng, RT | 1 |
Chew, KS | 1 |
Choong, CL | 1 |
Song, ZL | 1 |
Teh, JKL | 1 |
Koay, ZL | 1 |
Wong, SY | 1 |
Kam, CC | 1 |
Ranai, NBM | 1 |
Lee, WS | 1 |
Wang, Y | 3 |
Zhou, C | 1 |
Fu, Y | 1 |
Zhang, L | 2 |
Liu, S | 1 |
Cai, L | 3 |
Jiang, Z | 1 |
Xu, X | 1 |
Feng, L | 3 |
Gao, Y | 4 |
Lu, L | 1 |
Wu, C | 1 |
Lu, BJ | 1 |
Xie, D | 1 |
Wang, Z | 3 |
Bahaji Azami, NL | 1 |
An, YT | 1 |
Wang, HJ | 1 |
Ye, G | 1 |
Sun, MY | 1 |
Li, ZH | 1 |
Xie, ZY | 1 |
Ouyang, XX | 1 |
Huang, KZ | 1 |
Yu, XP | 2 |
Zhao, YL | 1 |
Zhang, YH | 1 |
Zhu, DH | 1 |
Yu, J | 1 |
Li, LJ | 3 |
Warrillow, S | 2 |
Fisher, C | 1 |
Bellomo, R | 2 |
Liotta, EM | 1 |
Kimberly, WT | 1 |
Zoica, BS | 1 |
Deep, A | 2 |
Robinson, AM | 1 |
Karvellas, CJ | 4 |
Dionne, JC | 1 |
Featherstone, R | 1 |
Sebastianski, M | 1 |
Vandermeer, B | 1 |
Rewa, OG | 1 |
Varghese, J | 1 |
Joshi, V | 1 |
Bollipalli, MK | 1 |
Malleeswaran, S | 1 |
Patcha, R | 1 |
Nair, H | 1 |
Vij, V | 1 |
Sachan, D | 1 |
Subramanian, P | 1 |
Jain, M | 1 |
Venkataraman, J | 1 |
Li, L | 1 |
Liu, P | 3 |
Li, K | 1 |
Lin, F | 1 |
Ji, CC | 1 |
Wang, YG | 1 |
Xu, B | 1 |
Mu, JS | 1 |
Zhou, YS | 1 |
Sarici, KB | 1 |
Karakas, S | 1 |
Otan, E | 1 |
Ince, V | 1 |
Koc, C | 1 |
Koc, S | 1 |
Bayraktar, H | 1 |
Aydin, C | 1 |
Kayaalp, C | 1 |
Gungor, S | 1 |
Kablan, Y | 1 |
Yilmaz, S | 1 |
Wei, YL | 1 |
Tian, Q | 1 |
Zhao, XX | 1 |
Qiu, GZ | 1 |
Xu, Y | 1 |
He, GL | 2 |
Zhou, CJ | 1 |
Cheng, Y | 1 |
Jiang, ZS | 2 |
Pan, MX | 2 |
Cardoso, FS | 2 |
Gottfried, M | 3 |
Tujios, S | 2 |
Olson, JC | 2 |
Kedia, S | 1 |
Sharma, H | 3 |
Vasudevan, S | 1 |
Sonika, U | 1 |
Upadhyaya, AD | 1 |
Acharya, SK | 5 |
Stravitz, RT | 1 |
Durkalski, V | 1 |
Fontana, RJ | 1 |
Hanje, AJ | 1 |
Koch, D | 1 |
Hameed, B | 1 |
Ganger, D | 1 |
Subramanian, RM | 1 |
Bukofzer, S | 1 |
Ravis, WR | 1 |
Clasen, K | 1 |
Sherker, A | 1 |
Little, L | 1 |
Lee, WM | 1 |
Kalal, C | 1 |
Shukla, A | 1 |
Mohanka, R | 1 |
Shah, S | 1 |
Weng, J | 1 |
Li, Y | 2 |
Peng, Q | 1 |
Mallet, M | 1 |
Weiss, N | 1 |
Thabut, D | 1 |
Rudler, M | 1 |
Fujiwara, K | 1 |
Yasui, S | 1 |
Yokosuka, O | 1 |
Oda, S | 1 |
Kato, N | 1 |
Wang, W | 1 |
Lu, H | 1 |
Lu, X | 1 |
Wang, D | 1 |
Dai, W | 1 |
Wang, J | 1 |
Xie, G | 1 |
Wang, X | 4 |
Jiang, R | 1 |
Zhao, A | 1 |
Yan, J | 1 |
Zheng, X | 1 |
Huang, F | 1 |
Liu, X | 3 |
Panee, J | 1 |
Rajani, C | 1 |
Yao, C | 1 |
Yu, H | 1 |
Jia, W | 2 |
Sun, B | 2 |
Chien, MM | 1 |
Chang, MH | 1 |
Chang, KC | 1 |
Lu, FT | 1 |
Chiu, YC | 1 |
Chen, HL | 1 |
Ni, YH | 1 |
Hsu, HY | 1 |
Wu, JF | 1 |
Sheikh, MF | 1 |
Mookerjee, RP | 1 |
Agarwal, B | 1 |
Jalan, R | 13 |
Jayakumar, AR | 5 |
Ruiz-Cordero, R | 1 |
Tong, XY | 2 |
Norenberg, MD | 7 |
Drolz, A | 1 |
Jäger, B | 1 |
Wewalka, M | 1 |
Saxa, R | 1 |
Horvatits, T | 1 |
Roedl, K | 1 |
Perkmann, T | 1 |
Zauner, C | 1 |
Kramer, L | 3 |
Ferenci, P | 2 |
Fuhrmann, V | 1 |
Al-Chalabi, A | 1 |
Matevossian, E | 1 |
V Thaden, AK | 1 |
Luppa, P | 1 |
Neiss, A | 1 |
Schuster, T | 1 |
Yang, Z | 1 |
Schreiber, C | 1 |
Schimmel, P | 1 |
Nairz, E | 1 |
Perren, A | 1 |
Radermacher, P | 1 |
Huber, W | 1 |
Schmid, RM | 1 |
Kreymann, B | 1 |
Prazak, J | 3 |
Laszikova, E | 3 |
Pantoflicek, T | 2 |
Ryska, O | 3 |
Koblihova, E | 2 |
Ryska, M | 3 |
Chastre, A | 3 |
Bélanger, M | 5 |
Nguyen, BN | 2 |
Butterworth, RF | 20 |
Zhang, S | 1 |
Chen, L | 1 |
Liu, T | 1 |
Scott, TR | 1 |
Kronsten, VT | 1 |
Hughes, RD | 2 |
Shawcross, DL | 1 |
Valdes, V | 1 |
Shamaladevi, N | 1 |
Gonzalez, W | 1 |
Rustom, N | 1 |
Bost, M | 1 |
Cour-Andlauer, F | 1 |
Lachaux, A | 1 |
Brunet, AS | 1 |
Boillot, O | 1 |
Bordet, F | 1 |
Valla, F | 1 |
Richard, N | 1 |
Javouhey, E | 1 |
Vargha, R | 1 |
Mostafa, G | 1 |
Burda, G | 1 |
Hermon, M | 1 |
Trittenwein, G | 1 |
Gole, J | 1 |
Mondal, P | 1 |
Trigun, SK | 1 |
Zhao, P | 1 |
Wang, CY | 1 |
Liu, WW | 1 |
Yu, LM | 1 |
Sun, YR | 1 |
Kristiansen, RG | 2 |
Rose, CF | 3 |
Fuskevåg, OM | 2 |
Mæhre, H | 1 |
Revhaug, A | 5 |
Ytrebø, LM | 6 |
Kodali, S | 1 |
McGuire, BM | 1 |
Shi, XL | 1 |
Yan, Y | 1 |
Ma, H | 1 |
Sun, L | 1 |
Huang, P | 1 |
Ni, X | 1 |
Zhao, X | 1 |
Ren, H | 1 |
Hu, D | 1 |
Zhou, Y | 1 |
Tian, F | 1 |
Ji, Y | 1 |
Cheng, X | 1 |
Pan, G | 1 |
Ding, YT | 3 |
Hui, L | 1 |
Laemmle, A | 1 |
Gallagher, RC | 1 |
Keogh, A | 1 |
Stricker, T | 1 |
Gautschi, M | 1 |
Nuoffer, JM | 1 |
Baumgartner, MR | 1 |
Häberle, J | 2 |
Zhang, J | 1 |
Xu, P | 1 |
Zhong, Z | 1 |
Liu, C | 1 |
Ling, Z | 1 |
Chen, Y | 6 |
Shu, N | 1 |
Zhao, K | 1 |
Liu, L | 1 |
Hertz, L | 1 |
Song, D | 1 |
Peng, L | 2 |
Stewart, CE | 1 |
Dhawan, A | 2 |
Douiri, A | 1 |
Cortes, M | 1 |
Vilca-Melendez, H | 1 |
Heaton, N | 1 |
Niranjan-Azadi, AM | 1 |
Araz, F | 1 |
Patel, YA | 1 |
Alachkar, N | 1 |
Alqahtani, S | 1 |
Cameron, AM | 1 |
Stevens, RD | 1 |
Gurakar, A | 1 |
Özçay, F | 2 |
Karadağ Öncel, E | 1 |
Barış, Z | 1 |
Canan, O | 1 |
Moray, G | 1 |
Haberal, M | 2 |
De Las Heras, J | 1 |
Aldámiz-Echevarría, L | 1 |
Martínez-Chantar, ML | 1 |
Delgado, TC | 1 |
Jamshidzadeh, A | 1 |
Heidari, R | 1 |
Abasvali, M | 1 |
Zarei, M | 1 |
Ommati, MM | 1 |
Abdoli, N | 1 |
Khodaei, F | 1 |
Yeganeh, Y | 1 |
Jafari, F | 1 |
Zarei, A | 1 |
Latifpour, Z | 1 |
Mardani, E | 1 |
Azarpira, N | 1 |
Asadi, B | 1 |
Najibi, A | 1 |
Popek, M | 1 |
Bobula, B | 1 |
Sowa, J | 1 |
Hess, G | 1 |
Polowy, R | 1 |
Filipkowski, RK | 1 |
Frontczak-Baniewicz, M | 1 |
Zabłocka, B | 1 |
Albrecht, J | 1 |
Zielińska, M | 1 |
Cauli, O | 2 |
Rodrigo, R | 2 |
Boix, J | 2 |
Piedrafita, B | 1 |
Agusti, A | 2 |
Felipo, V | 2 |
Banas, A | 1 |
Teratani, T | 1 |
Yamamoto, Y | 1 |
Tokuhara, M | 1 |
Takeshita, F | 1 |
Osaki, M | 1 |
Kato, T | 1 |
Okochi, H | 1 |
Ochiya, T | 1 |
Takahashi, K | 1 |
Umehara, Y | 1 |
Umehara, M | 1 |
Nishimura, A | 1 |
Narumi, S | 1 |
Toyoki, Y | 1 |
Hakamada, K | 1 |
Yoshihara, S | 1 |
Sasaki, M | 1 |
Lu, BR | 1 |
Gralla, J | 1 |
Liu, E | 2 |
Dobyns, EL | 2 |
Narkewicz, MR | 2 |
Sokol, RJ | 2 |
Bjerring, PN | 2 |
Eefsen, M | 1 |
Hansen, BA | 1 |
Larsen, FS | 5 |
Romero-Gómez, M | 2 |
Jover, M | 1 |
Galán, JJ | 1 |
Ruiz, A | 1 |
Jiang, W | 5 |
Desjardins, P | 8 |
Kitzberger, R | 1 |
Funk, GC | 1 |
Holzinger, U | 1 |
Miehsler, W | 1 |
Kaider, A | 1 |
Madl, C | 1 |
Maehre, H | 1 |
Kalstad, T | 1 |
Cobos, MJ | 1 |
Chavarria, L | 1 |
Oria, M | 1 |
Romero-Gimenez, J | 1 |
Alonso, J | 1 |
Lope-Piedrafita, S | 1 |
Cordoba, J | 2 |
Herrera, DJ | 1 |
Hutchin, T | 1 |
Fullerton, D | 1 |
Gray, G | 1 |
Rama Rao, KV | 3 |
Reddy, PV | 1 |
Tong, X | 2 |
Zafirova, Z | 1 |
O'connor, M | 1 |
Yang, X | 1 |
Bosoi, CR | 1 |
Tremblay, M | 1 |
Du, WB | 2 |
Pan, XP | 2 |
Teixeira, AR | 1 |
Machado, MC | 1 |
Kubrusly, MS | 1 |
Molan, NT | 1 |
Bellodi-Privato, M | 1 |
Leite, KR | 1 |
D'Albuquerque, LA | 1 |
Wright, G | 2 |
Sharifi, Y | 1 |
Li, J | 1 |
Zhao, W | 1 |
Bernal, W | 3 |
Auzinger, G | 3 |
Wendon, J | 3 |
Curtis, KM | 1 |
López-Larrubia, P | 1 |
Nieto-Charques, L | 1 |
Cerdán, S | 1 |
Zwirner, K | 1 |
Thiel, C | 2 |
Thiel, K | 2 |
Morgalla, MH | 2 |
Königsrainer, A | 2 |
Schenk, M | 2 |
Yu, CB | 1 |
Lv, GL | 1 |
Avraham, Y | 1 |
Grigoriadis, N | 1 |
Poutahidis, T | 1 |
Vorobiev, L | 1 |
Magen, I | 1 |
Ilan, Y | 1 |
Mechoulam, R | 1 |
Berry, E | 1 |
Faghfoury, H | 1 |
Baruteau, J | 1 |
de Baulny, HO | 1 |
Schulze, A | 1 |
García-Martínez, R | 1 |
Frühauf, NR | 1 |
Radunz, S | 1 |
Grabellus, F | 1 |
Laube, T | 1 |
Uerschels, AK | 1 |
Kaiser, GM | 1 |
Chang, CC | 1 |
Wang, SS | 2 |
Huang, HC | 2 |
Chan, CY | 2 |
Lee, FY | 2 |
Lin, HC | 2 |
Nong, JY | 1 |
Chuang, CL | 1 |
Lee, SD | 2 |
Glassford, NJ | 1 |
Farley, KJ | 1 |
Ozanne, B | 1 |
Nelson, J | 1 |
Cousineau, J | 1 |
Lambert, M | 1 |
Phan, V | 1 |
Mitchell, G | 1 |
Alvarez, F | 1 |
Ducruet, T | 1 |
Jouvet, P | 1 |
Etspüler, A | 1 |
Schenk, T | 1 |
Arkadopoulos, N | 1 |
Defterevos, G | 1 |
Nastos, C | 1 |
Papalois, A | 1 |
Kalimeris, K | 1 |
Papoutsidakis, N | 1 |
Kampouroglou, G | 1 |
Kypriotis, D | 1 |
Pafiti, A | 1 |
Kostopanagiotou, G | 1 |
Smyrniotis, V | 1 |
Kodras, K | 1 |
Bikhchandani, J | 1 |
Metcalfe, M | 1 |
Illouz, S | 1 |
Puls, F | 1 |
Dennison, A | 1 |
Vaquero, J | 4 |
Thumburu, KK | 1 |
Taneja, S | 1 |
Vasishta, RK | 1 |
Dhiman, RK | 1 |
Kumar, R | 2 |
Goyal, R | 1 |
Kumar, A | 1 |
Khanal, S | 2 |
Prakash, S | 2 |
Gupta, SD | 1 |
Panda, SK | 2 |
Du, T | 1 |
Cooper, AJ | 1 |
Beauchesne, E | 1 |
Bémeur, C | 1 |
Cichoż-Lach, H | 1 |
Michalak, A | 4 |
Nibourg, GA | 1 |
Hoekstra, R | 1 |
van der Hoeven, TV | 1 |
Ackermans, MT | 1 |
Hakvoort, TB | 1 |
van Gulik, TM | 2 |
Chamuleau, RA | 3 |
Zhou, X | 1 |
Yang, Y | 1 |
Zhao, L | 1 |
Miao, J | 1 |
Ding, J | 1 |
Fan, D | 1 |
Mundt, A | 1 |
Puhl, G | 1 |
Müller, A | 1 |
Sauer, I | 1 |
Müller, C | 1 |
Richard, R | 1 |
Fotopoulou, C | 1 |
Doll, R | 1 |
Gäbelein, G | 1 |
Höhn, W | 1 |
Hofbauer, R | 1 |
Neuhaus, P | 1 |
Gerlach, J | 1 |
Novelli, G | 1 |
Rossi, M | 1 |
Pretagostini, R | 1 |
Poli, L | 1 |
Novelli, L | 1 |
Berloco, P | 1 |
Ferretti, G | 1 |
Iappelli, M | 1 |
Cortesini, R | 1 |
Clemmesen, O | 2 |
Abrahamse, SL | 1 |
van de Kerkhove, MP | 2 |
Sosef, MN | 1 |
Hartman, R | 1 |
Zwingmann, C | 2 |
Chatauret, N | 6 |
Leibfritz, D | 1 |
Rose, C | 9 |
Qiu, YD | 1 |
Chen, Z | 2 |
Xu, QX | 1 |
Zhang, HY | 1 |
Tang, Q | 1 |
Yu, DC | 1 |
Rahman, TM | 1 |
Hodgson, HJ | 1 |
Shawcross, D | 2 |
Davies, N | 1 |
Lorenti, A | 1 |
Barbich, M | 1 |
de Santibáñes, M | 1 |
Ielpi, M | 1 |
Vazquez, JC | 1 |
Sorroche, P | 1 |
Argibay, P | 1 |
Chung, C | 1 |
Cahill, ME | 1 |
Blei, AT | 5 |
Di Florio, E | 1 |
Scuderi, V | 1 |
Mancini, A | 1 |
Belli, A | 1 |
Bracco, A | 1 |
Scala, D | 1 |
Scala, S | 1 |
Zeuli, L | 1 |
Di Nicuolo, G | 1 |
Amoroso, P | 1 |
Calise, F | 1 |
Olde Damink, SW | 3 |
Hayes, PC | 2 |
Deutz, NE | 5 |
Lee, A | 2 |
Yano, M | 1 |
Adachi, N | 2 |
Liu, K | 2 |
Arai, T | 2 |
Kobayashi, N | 3 |
Suzuki, S | 1 |
Soto-Gutierrez, A | 1 |
Rivas-Carrillo, JD | 2 |
Tanaka, K | 2 |
Navarro-Alvarez, N | 2 |
Fukazawa, T | 1 |
Narushima, M | 2 |
Miki, A | 2 |
Okitsu, T | 2 |
Amemiya, H | 1 |
Tanaka, N | 3 |
Ott, P | 3 |
Lee, KU | 1 |
Zheng, LX | 1 |
Cho, YB | 1 |
Kim, KH | 1 |
Ha, J | 1 |
Suh, KS | 1 |
Jung, SE | 1 |
Kundra, A | 1 |
Jain, A | 1 |
Banga, A | 1 |
Bajaj, G | 1 |
Kar, P | 1 |
Bhatia, V | 1 |
Singh, R | 1 |
MacKenzie, T | 1 |
Parikh, CR | 1 |
Karrer, FM | 1 |
Sen, S | 3 |
Davies, NA | 3 |
Nedredal, GI | 3 |
Drevland, SS | 1 |
Kjønnø, M | 1 |
Prinzen, FW | 1 |
Hodges, SJ | 1 |
Williams, R | 2 |
Gutierrez, AS | 1 |
Noguchi, H | 2 |
O'Beirne, JP | 1 |
Chouhan, M | 1 |
Rao, KV | 2 |
Raghavan, M | 1 |
Marik, PE | 1 |
Ten Have, GA | 1 |
Hodges, S | 1 |
Chiu, A | 1 |
Chan, LM | 1 |
Fan, ST | 1 |
Kawazoe, Y | 1 |
Eguchi, S | 1 |
Sugiyama, N | 1 |
Kamohara, Y | 1 |
Fujioka, H | 1 |
Kanematsu, T | 1 |
Strauss, GI | 1 |
Karakayali, H | 1 |
Ekici, Y | 1 |
Bilezikci, B | 1 |
Arslan, G | 1 |
Chang, FY | 1 |
Chu, CJ | 1 |
Chen, YC | 1 |
Wolff, B | 1 |
Machill, K | 1 |
Schumacher, D | 1 |
Schulzki, I | 1 |
Hall, C | 1 |
Sizer, E | 2 |
Panickar, KS | 1 |
Deshpande, G | 1 |
Motoki, A | 1 |
Mitsuyo, T | 1 |
Nagaro, T | 1 |
Clay, AS | 1 |
Hainline, BE | 1 |
Davern, TJ | 1 |
Dethloff, TJ | 1 |
Knudsen, GM | 1 |
Yang, WS | 1 |
Tan, HK | 1 |
Lui, HF | 1 |
Chow, PK | 1 |
Choong, HL | 1 |
Wong, KS | 1 |
de Knegt, RJ | 3 |
Schalm, SW | 3 |
van der Rijt, CC | 1 |
Fekkes, D | 1 |
Dalm, E | 1 |
Hekking-Weyma, I | 1 |
Mans, AM | 1 |
DeJoseph, MR | 1 |
Hawkins, RA | 1 |
Gramsbergen, JB | 1 |
Groeneweg, M | 1 |
Hekking-Weijma, I | 1 |
Itzhak, Y | 1 |
Roig-Cantisano, A | 1 |
Dombro, RS | 1 |
Dejong, CH | 1 |
Soeters, PB | 1 |
Watanabe, A | 1 |
Tsuchida, T | 1 |
Kuwabara, Y | 1 |
Knecht, K | 1 |
Quack, G | 1 |
Kircheis, G | 1 |
Conn, HO | 2 |
Miyazaki, M | 1 |
Fukaya, K | 1 |
Inoue, Y | 1 |
Sakaguchi, M | 1 |
Uemura, T | 1 |
Kondo, A | 1 |
Namba, M | 1 |
Pannunzio, M | 1 |
Rambaldi, A | 1 |
Clemmesen, JO | 2 |
Kondrup, J | 2 |
Horslen, SP | 1 |
Hammel, JM | 1 |
Fristoe, LW | 1 |
Kangas, JA | 1 |
Collier, DS | 1 |
Sudan, DL | 1 |
Langnas, AN | 1 |
Dixon, RS | 1 |
Prentice, ED | 1 |
Shaw, BW | 1 |
Fox, IJ | 1 |
Nielsen, LB | 1 |
Nagaki, M | 1 |
Miki, K | 1 |
Kim, YI | 1 |
Ishiyama, H | 1 |
Hirahara, I | 1 |
Takahashi, H | 1 |
Sugiyama, A | 1 |
Muto, Y | 1 |
Moriwaki, H | 1 |
Takeyama, O | 1 |
Ikai, I | 1 |
Yagi, T | 1 |
Satoh, S | 1 |
Kanazawa, A | 1 |
Uesugi, T | 1 |
Nishitai, R | 1 |
Okabe, H | 1 |
Katsura, N | 1 |
Terajima, H | 1 |
Yamaoka, Y | 1 |
Awad, SS | 1 |
Swaniker, F | 1 |
Magee, J | 1 |
Punch, J | 1 |
Bartlett, RH | 1 |
Venkatasubramanian, PN | 1 |
Tom, B | 1 |
Wyrwicz, AM | 1 |
Therrien, G | 1 |
De Bartolo, L | 1 |
Bader, A | 1 |
Takeshita, K | 1 |
Ishibashi, H | 1 |
Kodama, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury[NCT01548690] | Phase 2 | 47 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
Safety and Efficacy of Steroids in the Management of Fulminant Hepatic Failure Due to Hepatitis A Virus in the Pediatric Age Group[NCT02375867] | Phase 4 | 33 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
Brain Energy Metabolism in Patients With Acute Hepatic Encephalopathy Measured With PET[NCT00424957] | 18 participants (Anticipated) | Observational | 2006-11-30 | Completed | |||
Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure: A Double- Blind, Randomized, Placebo- Controlled Study[NCT00470314] | Phase 2 | 150 participants (Actual) | Interventional | 2005-01-31 | Active, not recruiting | ||
The Effectiveness of L-ornithine-L-aspartate on Plasma Ammonia in Cirrhotic Patients After TIPS Procedure: a Prospective, Randomized, Controlled, Open-label Clinical Trial[NCT01440829] | Phase 2/Phase 3 | 40 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To evaluate the effect of OCR-002 on ammonia levels in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: Baseline and 72 Hours
Intervention | Percent Change (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 41.2 |
Maximum Dose Level 6.65 g/24h | 16.6 |
Maximum Dose Level 10 g/24h | 41.8 |
Maximum Dose Level 20g/24h | 38.4 |
To evaluate the steady state pharmacokinetic and pharmacodynamic profile of OCR-002 in patients with impaired and intact renal function using urinary phenylacetylglutamine (PAGN) as a surrogate marker (NCT01548690)
Timeframe: 24 Hours after last infusion
Intervention | micrograms per millileter (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 65.6 |
Maximum Dose Level 6.65 g/24h | 32.2 |
Maximum Dose Level 10 g/24h | 33.4 |
Maximum Dose Level 20g/24h | 104.9 |
The orientation log focuses on orientation to place, time, and circumstance. There are 10 items on the orientation log, which are scored 0-3. A spontaneous correct response is awarded 3 points. A spontaneous response that is lacking or incorrect, but a correct response is provided following a logical cue is awarded 2 points. A score of 1 is given if spontaneous and cued responses are lacking or incorrect, but a correct response is provided in a recognition format. A score of 0 is given if the spontaneous, cued, or recognition format does not generate a correct answer. Scores from the 10 items are summed and the final score ranges from 0 to 30. (NCT01548690)
Timeframe: 30 Days
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 23.8 |
Maximum Dose Level 6.65 g/24h | 24.0 |
Maximum Dose Level 10 g/24h | 24.0 |
Maximum Dose Level 20g/24h | 24.0 |
The West Haven Criteria (WHC) for Hepatic Encephalopathy measures the severity of encephalopathy and patient's level of consciousness. The scale ranges from 0 to 4; a minimum score of 0 represents a better outcome, and a maximum total score of 4 represents a worse outcome. A score of 0 corresponds to normal consciousness and behavior and normal neurological examination. A score of 1 corresponds to mild lack of awareness, shortened attention span, and impaired addition or subtraction; mild asterixis or tremor. A score of 2 corresponds to lethargy, disorientated or inappropriate behavior, obvious asterixis; slurred speech. A score of 3 corresponds to somnolent but arousable, gross disorientation or bizarre behavior, muscle rigidity and clonus; hyperreflexia. A score of 4 corresponds to coma and decerebrate posturing. (NCT01548690)
Timeframe: 120 hours from start of infusion
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 2.4 |
Maximum Dose Level 6.65 g/24h | 3.2 |
Maximum Dose Level 10 g/24h | 1.6 |
Maximum Dose Level 20g/24h | 1.8 |
To evaluate the safety and tolerability of OCR-002 in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: 30 Days
Intervention | Participants (Count of Participants) |
---|---|
Maximum Dose Level 3.33 g/24h | 0 |
Maximum Dose Level 6.65 g/24h | 0 |
Maximum Dose Level 10 g/24h | 0 |
Maximum Dose Level 20g/24h | 0 |
45 reviews available for ammonium hydroxide and Acute Hepatic Failure
Article | Year |
---|---|
Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.
Topics: Ammonia; Animals; Brain; Brain Edema; Hepatic Encephalopathy; Humans; Liver Failure, Acute | 2020 |
Extracorporeal renal and liver support in pediatric acute liver failure.
Topics: Ammonia; Child; Extracorporeal Circulation; Humans; Liver Failure, Acute; Renal Dialysis; Water | 2021 |
Why and when to measure ammonemia in cirrhosis?
Topics: Ammonia; Diagnosis, Differential; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; L | 2018 |
Pathophysiology of cerebral oedema in acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain; Brain Edema; Capillary Permeability; Disea | 2013 |
Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
Topics: Acetylcysteine; Ammonia; Brain Edema; Free Radical Scavengers; Gastrointestinal Agents; Hepatic Ence | 2015 |
Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
Topics: Ammonia; Animals; Astrocytes; Brain; Cyclic GMP; Energy Metabolism; Glutamine; Hepatic Encephalopath | 2017 |
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
Topics: Ammonia; Animals; Benzoates; Drug Design; Glutamine; Humans; Liver Cirrhosis; Liver Diseases; Liver | 2017 |
The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema.
Topics: Ammonia; Animals; Brain; Brain Edema; Hepatic Encephalopathy; Humans; Hyperammonemia; Intracranial H | 2009 |
Gut ammonia production and its modulation.
Topics: Ammonia; Animals; Genetic Predisposition to Disease; Glutaminase; Glutamine; Hepatic Encephalopathy; | 2009 |
Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure.
Topics: Ammonia; Brain Edema; Hepatic Encephalopathy; Humans; Intracranial Hypertension; Liver Failure, Acut | 2010 |
The Na-K-Cl Co-transporter in astrocyte swelling.
Topics: Ammonia; Animals; Astrocytes; Brain; Brain Edema; Cell Size; Disease Models, Animal; Hepatic Encepha | 2010 |
Prognostic models for acute liver failure.
Topics: alpha-Fetoproteins; Ammonia; Humans; Lactic Acid; Liver Failure, Acute; Models, Biological; Phosphat | 2010 |
Acute liver failure.
Topics: Acetaminophen; Ammonia; Analgesics, Non-Narcotic; Chemical and Drug Induced Liver Injury; Emergency | 2010 |
Acute-on-chronic liver failure: the brain.
Topics: Ammonia; Brain; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Liver Failure, Acute | 2011 |
[Intracranial hypertension in acute liver failure and microdialysis].
Topics: Ammonia; Brain Edema; Glutamine; Humans; Intracranial Hypertension; Liver Failure, Acute; Microdialy | 2010 |
Detoxification as a treatment goal in hepatic failure.
Topics: Ammonia; Brain Edema; Extracorporeal Circulation; Hepatic Encephalopathy; Humans; Liver Failure, Acu | 2011 |
Therapeutic hypothermia in the management of acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Glucose; Humans; Hypothermia, Induced; Intracranial Pressure; Liver F | 2012 |
Neuropathology of acute liver failure.
Topics: Ammonia; Brain Edema; Humans; Intracranial Pressure; Liver Failure, Acute | 2012 |
Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined.
Topics: Ammonia; Biological Transport; Brain; Brain Edema; Glutamine; Hepatic Encephalopathy; Humans; Liver | 2012 |
Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Topics: Ammonia; Animals; Brain; Enzyme Inhibitors; Glutamate-Ammonia Ligase; Hepatic Encephalopathy; Homeos | 2013 |
Changes in cerebral oxidative metabolism in patients with acute liver failure.
Topics: Amino Acids; Ammonia; Animals; Brain; Brain Chemistry; Humans; Hyperammonemia; Lactic Acid; Liver Fa | 2013 |
Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain; Brain Edema; Cytokines; Hepatic Encephalopathy; Humans | 2013 |
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain; Brain Edema; gamma-Aminobutyric Acid; Hepatic Encephal | 2013 |
Splanchnic circulation and metabolism in patients with acute liver failure.
Topics: Amino Acids; Ammonia; Cardiac Output; Fatty Acids, Nonesterified; Hemodynamics; Humans; Liver; Liver | 2002 |
The molecular pathogenesis of hepatic encephalopathy.
Topics: Ammonia; Animals; Astrocytes; Brain; Gene Expression Regulation; Glutamine; Hepatic Encephalopathy; | 2003 |
Pathogenesis of hepatic encephalopathy in acute liver failure.
Topics: Ammonia; Brain; Brain Edema; Cerebrovascular Circulation; Hepatic Encephalopathy; Humans; Liver Cirr | 2003 |
Intracranial hypertension in acute liver failure: pathophysiological basis of rational management.
Topics: Ammonia; Animals; Brain Edema; Cerebrovascular Circulation; Environmental Monitoring; Humans; Intrac | 2003 |
Brain edema in acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Brain Edema; Dipeptides; Humans; Hypothermia, Induced; Intracranial Pr | 2003 |
Mild hypothermia for acute liver failure: a review of mechanisms of action.
Topics: Ammonia; Brain; Brain Edema; Cerebrovascular Circulation; Glucose; Hemodynamics; Humans; Hypothermia | 2005 |
Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis.
Topics: Ammonia; Animals; Astrocytes; Cerebral Cortex; Citric Acid Cycle; Hepatic Encephalopathy; Humans; Hy | 2005 |
Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Cerebrovascular Circulation; Encephalitis; Hepatic Encephalopathy; Hu | 2005 |
Therapy of intracranial hypertension in patients with fulminant hepatic failure.
Topics: Ammonia; Anesthetics, Intravenous; Brain; Cardiovascular Agents; Cerebrovascular Circulation; Electr | 2006 |
Effect of ammonia on astrocytic glutamate uptake/release mechanisms.
Topics: Ammonia; Animals; Astrocytes; Brain; Calcium; Cell Size; Cells, Cultured; Excitatory Amino Acid Tran | 2006 |
The effect of hyperventilation upon cerebral blood flow and metabolism in patients with fulminant hepatic failure.
Topics: Acetaminophen; Ammonia; Analgesics, Non-Narcotic; Animals; Carbon Dioxide; Cerebrovascular Circulati | 2007 |
[Disturbances in ammonia metabolism in hepatic failure].
Topics: Ammonia; Animals; Brain; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Mucosa; Kidney; | 2007 |
New concepts in the mechanism of ammonia-induced astrocyte swelling.
Topics: Ammonia; Animals; Astrocytes; Brain Edema; Cell Size; Energy Metabolism; Glutamine; Humans; Liver Fa | 2007 |
Hyperammonemia in the ICU.
Topics: Acute Disease; Algorithms; Ammonia; Astrocytes; Brain; Brain Edema; Cerebral Hemorrhage; Critical Ca | 2007 |
Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions.
Topics: Ammonia; Animals; Brain; Brain Diseases, Metabolic; Brain Edema; Energy Metabolism; Glutamine; Hepat | 2007 |
Brain edema in acute liver failure.
Topics: Ammonia; Brain Edema; Critical Care; Hepatic Encephalopathy; Humans; Liver Failure, Acute; Prognosis | 2008 |
Ammonia and glutamine metabolism during liver insufficiency: the role of kidney and brain in interorgan nitrogen exchange.
Topics: Ammonia; Animals; Brain; Glutamine; Humans; Kidney; Liver Failure, Acute; Nitrogen | 1996 |
Hepatic encephalopathy in acute liver failure: role of the glutamate system.
Topics: Ammonia; Animals; Biological Transport; Brain; Glutamic Acid; Hepatic Encephalopathy; Liver Failure, | 1997 |
Brain edema and intracranial hypertension: a focus for the use of liver support systems.
Topics: Ammonia; Animals; Bioreactors; Brain Edema; Cerebral Cortex; Glutamine; Intracranial Hypertension; I | 1997 |
Mild hypothermia prevents cerebral edema in acute liver failure.
Topics: Ammonia; Animals; Brain; Brain Edema; Extracellular Space; Glutamic Acid; Hypothermia, Induced; Live | 2001 |
Alterations in expression of genes coding for key astrocytic proteins in acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial | 2001 |
Review of a flat membrane bioreactor as a bioartificial liver.
Topics: Ammonia; Animals; Bioreactors; Biotransformation; Cells, Cultured; Diazepam; Hepatocytes; Humans; Li | 2001 |
5 trials available for ammonium hydroxide and Acute Hepatic Failure
Article | Year |
---|---|
[Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].
Topics: Adult; Aged; Ammonia; Bilirubin; Chronic Disease; Female; Follow-Up Studies; Humans; Kidney Function | 2002 |
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
Topics: Adult; Ammonia; Bilirubin; Female; Hepatic Encephalopathy; Humans; Liver Failure, Acute; Male; Middl | 2002 |
Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
Topics: Adult; Ammonia; Animals; Bilirubin; Female; Hepatitis B; Hepatocytes; Humans; Lactic Acid; Liver Fai | 2003 |
Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension.
Topics: Adult; Ammonia; Biomarkers; Blood Flow Velocity; Brain; Cerebrovascular Circulation; Female; Humans; | 2004 |
Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
Topics: Adolescent; Adult; Ammonia; Bilirubin; Blood Coagulation; Hemodiafiltration; Hepatic Encephalopathy; | 2001 |
131 other studies available for ammonium hydroxide and Acute Hepatic Failure
Article | Year |
---|---|
The successful application of hemoadsorption for extracorporeal liver support in a child with acute liver failure.
Topics: Ammonia; Bile Acids and Salts; Bilirubin; Child; Humans; Liver Failure, Acute; Male | 2022 |
Etiology, outcome and prognostic indicators of acute liver failure in Asian children.
Topics: Ammonia; Bilirubin; Child; Child, Preschool; Humans; Liver Failure, Acute; Liver Transplantation; Ma | 2022 |
Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system.
Topics: Adsorption; Ammonia; Animals; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Liv | 2023 |
BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
Topics: Ammonia; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Hepatic Encephalopathy; Inflamma | 2020 |
Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma.
Topics: Adult; Aged; Albumins; Ammonia; Bioartificial Organs; Cell Line, Tumor; Cell Survival; Culture Media | 2020 |
Correction and Control of Hyperammonemia in Acute Liver Failure: The Impact of Continuous Renal Replacement Timing, Intensity, and Duration.
Topics: Adult; Age Factors; Ammonia; APACHE; Body Weight; Continuous Renal Replacement Therapy; Female; Huma | 2020 |
Continuous renal replacement therapy and transplant-free survival in acute liver failure: protocol for a systematic review and meta-analysis.
Topics: Ammonia; Continuous Renal Replacement Therapy; Humans; Intensive Care Units; Liver Failure, Acute; M | 2020 |
Role of therapeutic plasma exchange in acute liver failure due to yellow phosphorus poisoning.
Topics: Adult; Ammonia; Female; Humans; Hypersensitivity; Hypotension; International Normalized Ratio; Liver | 2020 |
Predictive Value of Blood Ammonia in the Prognosis of Acute Liver Failure Evaluated by Receiver Operating Characteristic Curves.
Topics: Ammonia; Humans; Liver Failure, Acute; Prognosis; Retrospective Studies; ROC Curve | 2021 |
Can Patients Who Develop Cerebral Death in Fulminant Liver Failure Despite Liver Transplantation Be Previously Forseen?
Topics: Adolescent; Adult; Aged; Ammonia; Bilirubin; Biomarkers; Brain Death; Case-Control Studies; Child; C | 2017 |
Association between MFN2 gene polymorphisms and the risk and prognosis of acute liver failure: a case-control study in a Chinese population.
Topics: Adult; Ammonia; Asian People; Case-Control Studies; China; Female; Gene Frequency; Genetic Predispos | 2017 |
Artificial liver support in pigs with acetaminophen-induced acute liver failure.
Topics: Acetaminophen; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Cell Nucleus; Creatinine; D | 2017 |
Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.
Topics: Adult; Ammonia; Female; Humans; Liver Failure, Acute; Male; Middle Aged; Renal Replacement Therapy; | 2018 |
Predictors of infection in viral-hepatitis related acute liver failure.
Topics: Adult; Ammonia; Bacterial Infections; Biomarkers; Brain Edema; Female; Fungi; Gram-Negative Bacteria | 2017 |
Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
Topics: Acetates; Adolescent; Adult; Aged; Ammonia; Female; Glutamine; Humans; Hyperammonemia; Kidney Functi | 2018 |
Should venous ammonia be used in decision-making acute liver failure patients?
Topics: Ammonia; Hepatic Encephalopathy; Humans; Liver Failure, Acute; Renal Replacement Therapy | 2018 |
Reply.
Topics: Ammonia; Humans; Liver Failure, Acute; Renal Replacement Therapy | 2018 |
Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure.
Topics: Ammonia; Animals; Disease Models, Animal; Galactosamine; Intracranial Pressure; Liver Failure, Acute | 2017 |
A Role of Renal Replacement Therapy for Acute Liver Failure.
Topics: Ammonia; Humans; Liver Failure, Acute; Renal Dialysis; Renal Replacement Therapy | 2018 |
Effect of tumor necrosis factor-α on the expression of the ammonia transporter Rhcg in the brain in mice with acute liver failure.
Topics: Ammonia; Analysis of Variance; Animals; Brain; Cation Transport Proteins; Disease Models, Animal; Do | 2018 |
Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure.
Topics: Ammonia; Animals; Bile Acids and Salts; Cell Line; Disease Models, Animal; End Stage Liver Disease; | 2018 |
Prognostic parameters of pediatric acute liver failure and the role of plasma exchange.
Topics: Adolescent; alpha-Fetoproteins; Ammonia; Antithyroid Agents; Chemical and Drug Induced Liver Injury; | 2019 |
Prognostic Role of Ammonia in Patients With Cirrhosis.
Topics: Adult; Ammonia; Biomarkers; Biopsy, Needle; Case-Control Studies; Cohort Studies; Female; Hospitals, | 2019 |
Brain edema in acute liver failure: role of neurosteroids.
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain; Brain Edema; Cells, Cultured; Endothelial | 2013 |
Clinical impact of arterial ammonia levels in ICU patients with different liver diseases.
Topics: Adult; Aged; Ammonia; Austria; Biomarkers; Case-Control Studies; Disease-Free Survival; Female; Hepa | 2013 |
Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.
Topics: Ammonia; Animals; Blood Pressure; Cardiac Output; Creatinine; Dialysis; Disease Models, Animal; Fema | 2013 |
Cerebral microdialysis reflects the neuroprotective effect of fractionated plasma separation and adsorption in acute liver failure better and earlier than intracranial pressure: a controlled study in pigs.
Topics: Ammonia; Animals; Brain Edema; Cerebrum; Extracorporeal Circulation; Glucose; Glutamic Acid; Glutami | 2013 |
Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
Topics: Ammonia; Animals; Azoxymethane; Blood-Brain Barrier; Cytokines; Disease Models, Animal; Hepatic Ence | 2014 |
Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.
Topics: Ammonia; Bilirubin; Bioreactors; Cell Survival; Equipment Design; Hepatocytes; Humans; Liver Failure | 2014 |
Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Brain Edema; Cell Size; Cells, Cultured; Glyburide; Hypoglycemic Agent | 2014 |
Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease.
Topics: Acute Kidney Injury; Adolescent; Adsorption; Albumins; Ammonia; Bilirubin; Child; Copper; Creatinine | 2014 |
Treatment with N-acetylcystein and total plasma exchange for extracorporeal liver support in children with paracetamol intoxication.
Topics: Acetaminophen; Acetylcysteine; Ammonia; Analgesics, Non-Narcotic; Chemical and Drug Induced Liver In | 2014 |
Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.
Topics: Ammonia; Brain; Connexins; Energy Metabolism; Glutamic Acid; Heart Arrest; Hepatic Encephalopathy; H | 2014 |
Acute liver failure in Chinese children: a multicenter investigation.
Topics: Adolescent; Age Factors; Ammonia; Area Under Curve; Biomarkers; Blood Coagulation; Chi-Square Distri | 2014 |
L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.
Topics: Ammonia; Animals; Biomarkers; Brain; Disease Models, Animal; Female; Glycine; Hyperammonemia; Kidney | 2014 |
Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
Topics: Albumins; Ammonia; Animals; Bilirubin; Cell Line; Hepatocytes; Humans; Liver Failure, Acute; Liver, | 2016 |
Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).
Topics: Adolescent; Adult; Ammonia; Child; Female; Humans; Hyperammonemia; Liver; Liver Failure, Acute; Long | 2016 |
Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation.
Topics: Ammonia; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blo | 2016 |
Effect of Continuous Renal Replacement Therapy on Outcome in Pediatric Acute Liver Failure.
Topics: Ammonia; Child; Child, Preschool; Clinical Protocols; Female; Hospitals, University; Humans; Intensi | 2016 |
The use of temporary portocaval shunt as a technical aid in auxiliary orthotopic liver transplantation.
Topics: Acetaminophen; Adolescent; Adult; Allografts; Ammonia; Analgesics, Non-Narcotic; Biopsy; Female; Gra | 2016 |
Ammonia Level and Mortality in Acute Liver Failure: A Single-Center Experience.
Topics: Acute Kidney Injury; Adult; Ammonia; Female; Hepatic Encephalopathy; Humans; Liver Failure, Acute; L | 2016 |
Etiologies, outcomes, and prognostic factors of pediatric acute liver failure: A single center's experience in Turkey.
Topics: Adolescent; Ammonia; Bilirubin; Blood Coagulation Tests; Child; Child, Preschool; Female; Hepatitis | 2016 |
Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
Topics: Adenosine Triphosphate; Ammonia; Animals; Brain; Hepatic Encephalopathy; Hyperammonemia; Liver; Live | 2017 |
Cortical Synaptic Transmission and Plasticity in Acute Liver Failure Are Decreased by Presynaptic Events.
Topics: Ammonia; Animals; Cerebral Cortex; Cytokines; Disease Models, Animal; Liver Failure, Acute; Male; Mi | 2018 |
Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitator | 2008 |
Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
Topics: Adult; Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetra | 2009 |
Plasma exchange-based plasma recycling dialysis system as an artificial liver support.
Topics: Ammonia; Animals; Anion Exchange Resins; Bile Acids and Salts; Bilirubin; Charcoal; Dialysis; Diseas | 2008 |
Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure.
Topics: Ammonia; Bilirubin; Child; Female; Humans; Liver Failure, Acute; Male; Pediatrics; Predictive Value | 2008 |
Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.
Topics: Ammonia; Animals; Brain Edema; CD11b Antigen; Cytokines; Disease Models, Animal; Gene Expression; He | 2009 |
Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure.
Topics: Adult; Ammonia; APACHE; Female; Hepatic Encephalopathy; Humans; Intensive Care Units; Intracranial H | 2009 |
Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats.
Topics: Ammonia; Animals; Blotting, Western; Brain; Brain Chemistry; Disease Progression; Heme Oxygenase-1; | 2009 |
L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
Topics: Ammonia; Animals; Arteries; Brain; Drug Combinations; Extracellular Space; Intracranial Hypertension | 2009 |
Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain; Brain Edema; Diffusion Tensor Imaging; Glu | 2010 |
Non-specific interference in the measurement of plasma ammonia: importance of using a sample blank.
Topics: Ammonia; Artifacts; Enzyme Assays; Glutamate Dehydrogenase (NADP+); Humans; Liver; Liver Failure, Ac | 2010 |
Brain edema in acute liver failure: inhibition by L-histidine.
Topics: Ammonia; Animals; Brain; Brain Edema; Glutamate-Ammonia Ligase; Glutaminase; Glutamine; Heme Oxygena | 2010 |
Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress.
Topics: Aldehydes; Ammonia; Animals; Biomarkers; Blotting, Western; Brain; Disease Models, Animal; Frontal L | 2010 |
Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure.
Topics: Ammonia; Animals; Aquaporin 4; Astrocytes; Brain; Brain Edema; Cells, Cultured; Cytokines; Encephali | 2010 |
A new experimental model for acute hepatic failure in rats.
Topics: Ammonia; Animals; Bilirubin; Creatine; Disease Models, Animal; Hepatectomy; Hepatic Encephalopathy; | 2010 |
Blood-brain barrier in liver failure: are cracks appearing in the wall?
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain Edema; Hepatic Encephalopathy; Humans; Live | 2010 |
Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice.
Topics: Ammonia; Animals; Antigens, Polyomavirus Transforming; Cell Differentiation; Cell Division; Genetic | 2010 |
Brain aquaporin-4 in experimental acute liver failure.
Topics: Ammonia; Animals; Aquaporin 4; Astrocytes; Brain; Brain Edema; Calcium-Binding Proteins; Cell Membra | 2010 |
Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cerebellum; Cerebrum; En | 2011 |
Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure.
Topics: Albumins; Ammonia; Animals; Blood-Brain Barrier; Brain Chemistry; Disease Progression; Electroenceph | 2010 |
Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes.
Topics: Ammonia; Anesthetics, Local; Blood Proteins; Cell Line, Transformed; Cytochrome P-450 Enzyme System; | 2010 |
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
Topics: Ammonia; Animals; Bilirubin; Brain; Cannabidiol; Cognition; Female; Hepatic Encephalopathy; Liver; L | 2011 |
Transient fulminant liver failure as an initial presentation in citrullinemia type I.
Topics: Ammonia; Argininosuccinate Synthase; Base Sequence; Citrulline; Citrullinemia; Fatty Liver; Female; | 2011 |
Neuromonitoring in a porcine model of acute hepatic failure.
Topics: Ammonia; Animals; Brain Edema; Cerebral Cortex; Disease Models, Animal; Electroencephalography; Evok | 2011 |
Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
Topics: Ammonia; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Gene Expression Reg | 2011 |
Liver transplantation rapidly stops cerebral ammonia uptake in fulminant hepatic failure.
Topics: Adult; Ammonia; Brain; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Liver Failure, Acu | 2011 |
Threshold for toxicity from hyperammonemia in critically ill children.
Topics: Ammonia; Brain Edema; Child; Child, Preschool; Critical Illness; Encephalocele; Female; Humans; Hype | 2012 |
A simple dummy liver assist device prolongs anhepatic survival in a porcine model of total hepatectomy by slight hypothermia.
Topics: Ammonia; Animals; Body Temperature; Creatinine; Extracorporeal Circulation; Female; Hepatectomy; Hyp | 2011 |
Development of a porcine model of post-hepatectomy liver failure.
Topics: Ammonia; Animals; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Female; Hepatecto | 2011 |
Extracorporeal liver perfusion system for artificial liver support across a membrane.
Topics: Ammonia; Animals; Endogenous Retroviruses; Extracorporeal Circulation; Galactose; Liver Circulation; | 2011 |
Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Analysis of Variance; Female; Humans; Liver Failure, Acute; Logist | 2012 |
Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study.
Topics: Ammonia; Animals; Bilirubin; Biomarkers; Cerebrovascular Circulation; Disease Models, Animal; Equipm | 2012 |
Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Blood Chemical Analysis; Brain Edema; Child; Communicable Diseases | 2012 |
Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.
Topics: Ammonia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; CD40 Ligand; Cerebrum; Dise | 2012 |
Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
Topics: Amino Acids; Ammonia; Animals; Apolipoprotein A-I; Cell Line, Tumor; Cytochrome P-450 CYP3A; Disease | 2013 |
A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support.
Topics: Ammonia; Animals; Biochemistry; Bioreactors; Blood Flow Velocity; Extracorporeal Circulation; Glucos | 2002 |
Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system.
Topics: 7-Alkoxycoumarin O-Dealkylase; Ammonia; Animals; Butyrylcholinesterase; Cells, Cultured; Female; Hep | 2002 |
Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study.
Topics: Amino Acids; Ammonia; Animals; Blood; Body Water; Brain; Brain Edema; Carbon Isotopes; Glucose; Hepa | 2003 |
Mild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospects.
Topics: Ammonia; Brain; Brain Edema; Glutamic Acid; Humans; Hypothermia, Induced; Lactic Acid; Liver Failure | 2002 |
The development of a new bioartificial liver and its application in 12 acute liver failure patients.
Topics: Adolescent; Adult; Ammonia; Animals; Bilirubin; Disease Models, Animal; Equipment Design; Female; He | 2003 |
The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat.
Topics: Ammonia; Animals; Enzyme Inhibitors; Guanidines; Hepatic Encephalopathy; Liver; Liver Failure, Acute | 2003 |
Ammonium detoxification performed by porcine hepatocyte spheroids in a bioartificial liver for pediatric use: preliminary report.
Topics: Ammonia; Animals; Child; Diazepam; Equipment Design; Hepatocytes; Humans; Liver Failure, Acute; Live | 2003 |
Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.
Topics: Adult; Ammonia; Biomarkers; Brain; Cardiovascular System; Cerebrovascular Circulation; Female; Hemod | 2004 |
Flumazenil-induced improvement of the central dopaminergic system in rats with acute hepatic failure.
Topics: Ammonia; Anesthesia; Animals; Biogenic Monoamines; Brain Chemistry; Central Nervous System; Dopamine | 2005 |
Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure.
Topics: Albumins; Ammonia; Animals; CCAAT-Enhancer-Binding Protein-alpha; Cell Division; Child; Diazepam; DN | 2005 |
An experimental animal model of fulminant hepatic failure in pigs.
Topics: Acidosis; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Urea Nitrog | 2005 |
Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.
Topics: Adult; Ammonia; Brain Edema; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Intracranial H | 2005 |
Predictive value of arterial ammonia for complications and outcome in acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Epidemiologic Methods; Female; Hepatic Encephalopathy; | 2006 |
Predictive value of arterial ammonia for complications and outcome in acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Epidemiologic Methods; Female; Hepatic Encephalopathy; | 2006 |
Predictive value of arterial ammonia for complications and outcome in acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Epidemiologic Methods; Female; Hepatic Encephalopathy; | 2006 |
Predictive value of arterial ammonia for complications and outcome in acute liver failure.
Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Epidemiologic Methods; Female; Hepatic Encephalopathy; | 2006 |
Characterization of acute liver failure and development of a continuous risk of death staging system in children.
Topics: Ammonia; Bilirubin; Biomarkers; Child; Female; Follow-Up Studies; Humans; Liver Failure, Acute; Male | 2006 |
Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study.
Topics: Albumins; Ammonia; Animals; Brain Edema; Cerebrovascular Circulation; Disease Models, Animal; Female | 2006 |
Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure.
Topics: Ammonia; Animals; Antimetabolites; Antisense Elements (Genetics); Astrocytes; Blotting, Western; Bra | 2006 |
Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5.
Topics: Ammonia; Animals; Cell Culture Techniques; Cells, Cultured; Diazepam; Haplorhini; Hepatocytes; Lidoc | 2006 |
The role of infection and inflammation in the pathogenesis of hepatic encephalopathy and cerebral edema in acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Cytokines; Hepatic Encephalopathy; Humans; Infections; Inflammation; | 2006 |
Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure.
Topics: Ammonia; Animals; Gene Expression; Glutamate-Ammonia Ligase; Glutamine; Liver Failure, Acute; Male; | 2006 |
Functional evaluation of a new bioartificial liver system in vitro and in vitro.
Topics: Alanine Transaminase; Albumins; Ammonia; Animals; Bilirubin; Bioreactors; Cell Survival; Cells, Cult | 2006 |
Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure.
Topics: Ammonia; Animals; Biological Transport, Active; Female; Glutamic Acid; Glutamine; Hyperammonemia; Ki | 2006 |
Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Topics: Adult; Aged; Ammonia; Bilirubin; Blood Urea Nitrogen; Female; Hepatectomy; Hepatic Encephalopathy; H | 2006 |
Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Animals; Female; Hemodiafiltration; Hum | 2006 |
Pediatric liver transplantation for acute liver failure.
Topics: Adolescent; Ammonia; Cadaver; Child; Child, Preschool; Female; Humans; Infant; Liver Failure, Acute; | 2007 |
Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Anim | 2008 |
MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
Topics: Ammonia; Bilirubin; Female; Humans; Liver Diseases, Alcoholic; Liver Failure; Liver Failure, Acute; | 2007 |
Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure.
Topics: Adult; Aged; Ammonia; Brain Edema; Female; Hepatic Encephalopathy; Humans; Intracranial Hypertension | 2007 |
Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.
Topics: Ammonia; Animals; Brain Chemistry; Disease Models, Animal; Extracellular Space; Female; Glutamic Aci | 2007 |
Recovery of brain dopamine metabolism by branched-chain amino acids in rats with acute hepatic failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alanine Transaminase; Amino Acids; Amino Acids, Branched-Chain; Ammo | 2007 |
Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension.
Topics: Adult; Ammonia; Brain; Cross-Sectional Studies; Cytokines; Hepatic Encephalopathy; Humans; Interleuk | 2007 |
Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema.
Topics: Ammonia; Brain Edema; Humans; Liver Failure, Acute; Prognosis | 2007 |
Cerebral blood flow autoregulation in experimental liver failure.
Topics: Ammonia; Animals; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Anim | 2008 |
Variation in blood ammonia concentration with site of measurement and evidence of brain and muscle uptake in patients with acute liver failure.
Topics: Adult; Ammonia; Arteries; Brain; Female; Humans; Liver Failure, Acute; Male; Muscle, Skeletal; Veins | 2008 |
Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin.
Topics: Adult; Aged; Albumins; Ammonia; Bilirubin; Contraindications; Creatinine; Dialysis; Dialysis Solutio | 2008 |
Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.
Topics: Ammonia; Animals; Brain; Electroencephalography; Extracellular Space; Glutamates; Glutamic Acid; Hep | 1994 |
Metabolic abnormalities and grade of encephalopathy in acute hepatic failure.
Topics: Ammonia; Animals; Arginine; Aspartic Acid; Blood Glucose; Blood-Brain Barrier; Brain Chemistry; Brai | 1994 |
45CaCl2 autoradiography in brain from rabbits with encephalopathy from acute liver failure or acute hyperammonemia.
Topics: Acetates; Ammonia; Animals; Autoradiography; Blood Glucose; Brain; Brain Diseases; Calcium; Calcium | 1994 |
Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study.
Topics: Ammonia; Animals; Brain Edema; Disease Models, Animal; Electroencephalography; Hepatic Encephalopath | 1994 |
Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain.
Topics: Acetates; Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Liver Failure, Ac | 1995 |
Two models of acute hepatic failure with extensive hepatic necrosis and blood ammonia elevation in small animals.
Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Common Bile Duct; Disease Models, Animal; Emulsio | 1997 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sp | 1999 |
Hyperammonia and cerebral herniation: is an abnormality of ammonia metabolism responsible?
Topics: Ammonia; Brain; Encephalocele; Hepatic Encephalopathy; Humans; Intracranial Hypertension; Liver; Liv | 1999 |
Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure.
Topics: Ammonia; Animals; Antigens, Polyomavirus Transforming; Cell Differentiation; Cell Line; Cell Transpl | 2000 |
Hyperammonemia and intracranial hypertension: lying in wait for patients with hepatic disorders?
Topics: Ammonia; Encephalocele; Humans; Intracranial Hypertension; Liver Failure, Acute; Predictive Value of | 2000 |
Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure.
Topics: Ammonia; Animals; Brain; Brain Edema; Extracellular Space; Glutamic Acid; Hepatic Artery; Hepatic En | 2000 |
Splanchnic and leg exchange of amino acids and ammonia in acute liver failure.
Topics: Adult; Alanine; Amino Acids; Ammonia; Blood Urea Nitrogen; Citrulline; Female; Femoral Artery; Femor | 2000 |
Extracorporeal liver perfusion using human and pig livers for acute liver failure.
Topics: Adolescent; Adult; Ammonia; Animals; Antibodies, Anti-Idiotypic; Biopsy; Child; Endothelium, Vascula | 2000 |
Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure.
Topics: Adult; Amino Acids; Ammonia; Female; Humans; Liver Failure, Acute; Male; Plasmapheresis; Urea | 2001 |
Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.
Topics: Ammonia; Animals; Basement Membrane; Cells, Cultured; Collagen; Culture Media; Gels; Hepatocytes; La | 2001 |
Effects of prostaglandin E(1) on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure.
Topics: Alprostadil; Amino Acids; Amino Acids, Branched-Chain; Ammonia; Animals; Bile; Bile Acids and Salts; | 2001 |
Monitoring of brain water by chemical shift imaging during ammonia-induced brain swelling in rats after portacaval anastomosis.
Topics: Ammonia; Animals; Body Water; Brain Edema; Cerebral Cortex; Intracranial Hypertension; Liver Failure | 2001 |
Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure.
Topics: Ammonia; Animals; Brain; Brain Edema; Energy Metabolism; Hepatic Encephalopathy; Hypothermia, Induce | 2001 |
Hepatocellular transplantation for metabolic support in experimental acute ischemic liver failure in rats.
Topics: Ammonia; Animals; Blood Glucose; Gluconeogenesis; Ischemia; Liver; Liver Failure, Acute; Liver Trans | 1992 |